EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05

Yi Luo, Chao-Chi Yue

Journal of Gastroenterology · 22.05.2026

DOI: 10.1007/s00535-026-02441-1 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Gastroenterology, online erschienen am 22.05.2026. Verfasst von Yi Luo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Southwest Medical University, No. 1, Section 1, Xianglin Road, Longmatan District, Luzhou City, Sichuan Province, People's Republic of China. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Southwest Medical University, No. 1, Section 1, Xianglin Road, Longmatan District, Luzhou City, Sichuan Province, People's Republic of China.
  • Southwest Medical University, No. 1, Section 1, Xianglin Road, Longmatan District, Luzhou City, Sichuan Province, People's Republic of China. yuechaochi18@swmu.edu.cn.

Zitieren

APA

Luo, Y., & Yue, C. C. (2026). Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02441-1

Vancouver

Luo Y, Yue CC. Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02441-1

BibTeX
@article{Luo2026,
  author = {Luo, Yi and Yue, Chao-Chi},
  title = {Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02441-1}
}
Kostenlos starten →